Autolus Stock: Faces FDA Decision On CAR-T Therapy in November seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.
Obe-cel, a potentially transformational treatment for relapsed/refractory adult B-cell Acute Lymphoblastic Leukemia , on track for a Biologics License Application submission to the US Food & Drug.
Autolus Therapeutics plc (NASDAQ:AUTL) Q2 2023 Earnings Call Transcript August 6, 2023 Operator: Hello, ladies and gentlemen, and welcome to the Autolus Therapeutics Second Quarter 2023 Financial Results Conference. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that […]
Operator: Hello, ladies and gentlemen, and welcome to the Autolus Therapeutics Second Quarter 2023 Financial Results Conference. At this time, all participants are in a listen-only mode.
Autolus Therapeutics plc announced that Dr. Veronica Hersberger was appointed as Senior Vice President, Medical Affairs in Second Quarter 2023 and has started to build up this critical function as the.